Skip to main content
SpringerLink
Log in

Some Recent Randomized Clinical Trials in the Management of Atrial Fibrillation

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

It is not possible to review all the recent randomized clinical trials in management of atrial fibrillation. The author has chosen to select a few that illustrate key points. “Immediate” or “early” recurrence of atrial fibrillation after electrical cardioversion is an important part of inefficacy of drug therapy and more insight into the mechanisms of this phenomenon is needed. Two recent trials in which verapamil, a calcium channel blocker, and irbesartan, an angiotensin receptor blocking agent, added to a standard antiarrhythmic attenuated early recurrences of atrial fibrillation are of particular interest.

Trials of drugs and pacing for maintenance of sinus rhythm continue to demonstrate only modest efficacy. Amiodarone, the most effective agent, is not markedly better and there are concerns about its adverse effect profile during long-term use. Other nonpharmacologic therapies have not yet been, but will need to be, evaluated in properly designed randomized clinical trials with clinically important end-points.

The absence of a simple, highly effective treatment for the maintenance of sinus rhythm with few adverse effects has been part of the foundation for recent trials comparing the rate control strategy to the rhythm control strategy, particularly in the elderly patient. Six such trials have been completed and one is in progress. The data from these trials is quite consistent for the elderly patient with stroke risk factors and predominantly persistent atrial fibrillation: (1) any advantage for the rhythm control strategy remains unproven; (2) the rate control strategy has some clear advantages and should be considered more often as a primary approach in such patients; and (3) anticoagulation should not be discontinued in such high risk patients, even when it is felt that sinus rhythm has been maintained. Anticoagulation is under-utilized in this setting and alternatives to warfarin are badly needed. Trials in progress may be helpful in this regard.

Finally, primary prevention of atrial fibrillation needs more attention. Recent randomized trials with trandolapril after myocardial infarction and physiologic pacing have given some insight into how this might be accomplished.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. 2nd ed. Littleton, Massachusetts: PSG Publishing Company, Inc., 1985.

    Google Scholar 

  2. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 2001;38:1231–1265.

    Google Scholar 

  3. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:1600–1606.

    Google Scholar 

  4. Tieleman RG, De Langen C, Van Gelder, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;96:1542–1550.

    Google Scholar 

  5. DeSimone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patient with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810–814.

    Google Scholar 

  6. Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:Aprospective and randomized study. Circulation 2002;106:331–336.

    Google Scholar 

  7. Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm: A meta analysis of clinical trials. J Fam Pract 2000;49:1033–1046.

    Google Scholar 

  8. Wyse DG. Selection of endpoints in atrial fibrillation studies. J Cardiovasc Electrophysiol 2002;13:(Suppl)S47–S52.

    Google Scholar 

  9. Nichol G, McAlister F, Pham B, et al. Meta analysis of randomized controlled trials of effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002;87:535–543.

    Google Scholar 

  10. Singh S, Zoble RG, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patient with chronic atrial fibrillation or atrial flutter. The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study. Circulation 2000;102:2385–2390.

    Google Scholar 

  11. Torp-Pedersen C, Moeller M, Boch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 1999;341:857–865.

    Google Scholar 

  12. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913–920.

    Google Scholar 

  13. Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM Substudy of the First Antiarrhythmic Drug. J Am Coll Cardiol 2003;42:20–29.

  14. Pritchett ELC, Page RL, Connolly SJ, et al. Antiarrhythmic effects of azimilide in atrial fibrillation: Efficacy and doseresponse. J Am Coll Cardiol 2000;36:794–802.

    Google Scholar 

  15. Gillis Am, Wyse DG, Connolly SJ, et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553–2558.

    Google Scholar 

  16. Saksena S, Prakash A, Ziegler Phummel JD, Friedman P, Plumb VJ, Wyse DG, Johnson E, Fitts S, Mehra R. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002;40(6):1140–1150.

    Google Scholar 

  17. Segal JB, McNamara RL, Miller MR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000;49;47–59.

    Google Scholar 

  18. Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR modeswitching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study. Circulation 1997;96:2617–2624.

    Google Scholar 

  19. Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: A randomized, controlled study. Circulation 1998;98:953–960.

    Google Scholar 

  20. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol 1998;21:641–651.

    Google Scholar 

  21. Lee SH, Chen SA, Tai CT, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998;31:637–644.

    Google Scholar 

  22. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000;356:1789–1794.

    Google Scholar 

  23. Brignole M, Menozzi C, Gasparini M, et al. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002;23:892–900.

    Google Scholar 

  24. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: STAF study. J Am Coll Cardiol 2003;41:1690–1696.

    Google Scholar 

  25. Van Delder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with persistent atrial fibrillation. New Engl J Med 2002;347: 1834–1840.

    Google Scholar 

  26. Wyse DG, DiMarco J, Waldo A, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. New Engl J Med 2002;347:1825–1833.

    Google Scholar 

  27. Vora AM, Goyal VS, Naik AM, et al. Maintenance of sinus rhythm by amiodarone is superior to ventricular rate control in rheumatic atrial fibrillation: A blinded placebocontrolled study (Abstract). Pacing Clin Electrophysiol 2001;546.

  28. Connolly SJ. Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts. Am Heart J 2003;145:430–437.

    Google Scholar 

  29. Pedersen OD, Bagger H, Koeber L, Torp-Pedersen C for the TRACE Study Group. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376–380.

    Google Scholar 

  30. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000:342:1385–1391.

    Google Scholar 

  31. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854–1862.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Cardiac Sciences, University of Calgary/Calgary Health Region, Calgary, Alberta, Canada

    D. George Wyse

Authors
  1. D. George Wyse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. George Wyse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wyse, D.G. Some Recent Randomized Clinical Trials in the Management of Atrial Fibrillation. J Interv Card Electrophysiol 9, 223–228 (2003). https://doi.org/10.1023/A:1026292609252

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026292609252

Search

Navigation